Orbimed Advisors as of June 30, 2025
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 99 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sinovac Biotech SHS | 8.3 | $334M | 2.7M | 122.85 | |
| Boston Scientific Corporation (BSX) | 7.5 | $302M | 2.8M | 107.41 | |
| Eli Lilly & Co. (LLY) | 6.6 | $263M | 338k | 779.53 | |
| Edgewise Therapeutics (EWTX) | 5.1 | $203M | 16M | 13.11 | |
| Enliven Therapeutics (ELVN) | 4.0 | $160M | 8.0M | 20.06 | |
| Intuitive Surgical Com New (ISRG) | 3.9 | $158M | 291k | 543.41 | |
| Silverback Therapeutics (SPRY) | 3.6 | $145M | 8.3M | 17.45 | |
| Stryker Corporation (SYK) | 3.5 | $142M | 359k | 395.63 | |
| Edwards Lifesciences (EW) | 3.3 | $134M | 1.7M | 78.21 | |
| UnitedHealth (UNH) | 3.0 | $121M | 386k | 311.97 | |
| Argenx Se Sponsored Adr (ARGX) | 2.9 | $115M | 208k | 551.22 | |
| Alnylam Pharmaceuticals (ALNY) | 2.8 | $112M | 342k | 326.09 | |
| Natera (NTRA) | 2.5 | $100M | 593k | 168.94 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.3 | $94M | 210k | 445.20 | |
| Tenet Healthcare Corp Com New (THC) | 2.0 | $82M | 465k | 176.00 | |
| Caris Life Sciences (CAI) | 2.0 | $81M | 3.0M | 26.72 | |
| Disc Medicine (IRON) | 1.9 | $75M | 1.4M | 52.96 | |
| Arrivent Biopharma (AVBP) | 1.6 | $66M | 3.0M | 21.77 | |
| Sionna Therapeutics (SION) | 1.6 | $64M | 3.7M | 17.35 | |
| Upstream Bio (UPB) | 1.6 | $63M | 5.7M | 10.98 | |
| Neurocrine Biosciences (NBIX) | 1.4 | $55M | 439k | 125.69 | |
| Integer Hldgs (ITGR) | 1.3 | $53M | 433k | 122.97 | |
| Cg Oncology (CGON) | 1.3 | $53M | 2.0M | 26.00 | |
| Avidity Biosciences Ord (RNA) | 1.3 | $52M | 1.8M | 28.40 | |
| Si-bone (SIBN) | 1.2 | $49M | 2.6M | 18.82 | |
| Mbx Biosciences (MBX) | 1.1 | $46M | 4.0M | 11.41 | |
| Axsome Therapeutics (AXSM) | 1.1 | $45M | 428k | 104.39 | |
| Compass Therapeutics (CMPX) | 1.0 | $40M | 15M | 2.60 | |
| Cytokinetics Com New (CYTK) | 0.9 | $36M | 1.1M | 33.04 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $33M | 1.1M | 28.76 | |
| EXACT Sciences Corporation (EXAS) | 0.8 | $32M | 607k | 53.14 | |
| Third Harmonic Bio (THRD) | 0.8 | $31M | 5.8M | 5.43 | |
| Roivant Sciences SHS (ROIV) | 0.8 | $31M | 2.8M | 11.27 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $30M | 948k | 31.30 | |
| Neuropace (NPCE) | 0.7 | $29M | 2.6M | 11.14 | |
| Corvus Pharmaceuticals (CRVS) | 0.7 | $29M | 7.2M | 4.00 | |
| Terns Pharmaceuticals (TERN) | 0.7 | $28M | 7.6M | 3.73 | |
| Janux Therapeutics (JANX) | 0.7 | $28M | 1.2M | 23.10 | |
| Apellis Pharmaceuticals Call Option (APLS) | 0.7 | $27M | 1.5M | 17.31 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.6 | $25M | 1.2M | 20.74 | |
| Scpharmaceuticals (SCPH) | 0.6 | $23M | 6.1M | 3.81 | |
| Cytomx Therapeutics (CTMX) | 0.5 | $19M | 8.5M | 2.27 | |
| Thermo Fisher Scientific (TMO) | 0.5 | $19M | 47k | 405.46 | |
| Agios Pharmaceuticals (AGIO) | 0.5 | $19M | 558k | 33.26 | |
| Trevi Therapeutics (TRVI) | 0.5 | $18M | 3.3M | 5.47 | |
| Ikena Oncology Nonvoting | 0.4 | $16M | 12M | 1.34 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.4 | $16M | 5.9M | 2.68 | |
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $16M | 249k | 63.19 | |
| Forte Biosciences Com New (FBRX) | 0.4 | $16M | 1.2M | 12.93 | |
| Cullinan Oncology (CGEM) | 0.4 | $15M | 1.9M | 7.53 | |
| Keros Therapeutics (KROS) | 0.3 | $14M | 1.0M | 13.35 | |
| Rapt Therapeutics Com New (RAPT) | 0.3 | $13M | 1.6M | 8.00 | |
| Amicus Therapeutics (FOLD) | 0.3 | $13M | 2.3M | 5.73 | |
| Vir Biotechnology (VIR) | 0.3 | $12M | 2.4M | 5.04 | |
| Abcellera Biologics (ABCL) | 0.3 | $12M | 3.3M | 3.43 | |
| Akero Therapeutics (AKRO) | 0.3 | $11M | 211k | 53.36 | |
| Mineralys Therapeutics (MLYS) | 0.3 | $10M | 760k | 13.53 | |
| Dyne Therapeutics (DYN) | 0.2 | $9.8M | 1.0M | 9.52 | |
| C4 Therapeutics Com Stk (CCCC) | 0.2 | $9.8M | 6.8M | 1.43 | |
| Oric Pharmaceuticals (ORIC) | 0.2 | $9.1M | 899k | 10.15 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.2 | $9.0M | 417k | 21.70 | |
| Prelude Therapeutics (PRLD) | 0.2 | $8.8M | 11M | 0.81 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.2 | $8.1M | 1.2M | 6.90 | |
| Zai Lab Adr (ZLAB) | 0.2 | $8.1M | 231k | 34.97 | |
| Tarsus Pharmaceuticals (TARS) | 0.2 | $8.0M | 198k | 40.51 | |
| Aadi Bioscience (WHWK) | 0.2 | $7.8M | 4.2M | 1.87 | |
| Tyra Biosciences (TYRA) | 0.2 | $7.7M | 805k | 9.57 | |
| Astrazeneca Sponsored Adr Call Option | 0.2 | $7.0M | 100k | 69.88 | |
| Adicet Bio | 0.2 | $7.0M | 11M | 0.61 | |
| Iteos Therapeutics | 0.2 | $7.0M | 700k | 9.97 | |
| Pmv Pharmaceuticals (PMVP) | 0.2 | $6.9M | 6.5M | 1.06 | |
| Urogen Pharma (URGN) | 0.2 | $6.6M | 478k | 13.70 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.1 | $5.9M | 34k | 172.60 | |
| Alumis (ALMS) | 0.1 | $5.8M | 1.9M | 3.00 | |
| Jade Biosciences Com New (JBIO) | 0.1 | $5.3M | 531k | 9.99 | |
| Inspiremd (NSPR) | 0.1 | $4.8M | 2.1M | 2.27 | |
| Avalo Therapeutics Com New (AVTX) | 0.1 | $4.8M | 967k | 4.99 | |
| Ikena Oncology (IKNA) | 0.1 | $4.7M | 3.5M | 1.34 | |
| Repare Therapeutics Ord | 0.1 | $4.6M | 3.3M | 1.39 | |
| Immatics SHS (IMTX) | 0.1 | $3.9M | 720k | 5.38 | |
| Bioage Labs (BIOA) | 0.1 | $3.8M | 922k | 4.13 | |
| Q32 Bio (QTTB) | 0.1 | $3.4M | 2.3M | 1.49 | |
| Engene Holdings (ENGN) | 0.1 | $2.5M | 678k | 3.64 | |
| Passage Bio | 0.1 | $2.4M | 6.1M | 0.40 | |
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $2.0M | 313k | 6.41 | |
| Mural Oncology Pub Ord Shs (MURA) | 0.0 | $1.5M | 589k | 2.47 | |
| Insmed Com Par $.01 (INSM) | 0.0 | $1.4M | 14k | 100.64 | |
| Krystal Biotech (KRYS) | 0.0 | $1.3M | 9.2k | 137.46 | |
| Turnstone Biologics Corp (TSBX) | 0.0 | $1.1M | 3.1M | 0.36 | |
| Chemomab Therapeutics Sponsored Ads | 0.0 | $1.1M | 941k | 1.16 | |
| Traws Pharma Com New (TRAW) | 0.0 | $896k | 606k | 1.48 | |
| Kezar Life Sciences Com New (KZR) | 0.0 | $883k | 193k | 4.58 | |
| Alto Neuroscience Com Shs (ANRO) | 0.0 | $550k | 250k | 2.20 | |
| Dih Hldg Us Cl A | 0.0 | $469k | 1.9M | 0.24 | |
| Lyell Immunopharma Com New (LYEL) | 0.0 | $457k | 52k | 8.84 | |
| Korro Bio (KRRO) | 0.0 | $405k | 32k | 12.49 | |
| Xeris Pharmaceuticals (XERS) | 0.0 | $376k | 80k | 4.67 | |
| Inmune Bio Ord Put Option (INMB) | 0.0 | $116k | 50k | 2.31 | |
| Lakeshore Biopharma Ord Shs New (LSBCF) | 0.0 | $56k | 55k | 1.02 |
